Loneliness Group Intervention
Loneliness Group Intervention for Geriatric Psychiatry Inpatients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Serena Wong, PhD
- Phone Number: 47537 519-455-5110
- Email: serena.wong@sjhc.london.on.ca
Study Contact Backup
- Name: Frankie Lui, MSW
- Phone Number: 47028 5194555110
- Email: frankie.lui@sjhc.london.on.ca
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6C 0A7
- Parkwood Institute Mental Health
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Admission to geriatric psychiatry inpatient unit
Exclusion Criteria:
- Individuals who are disoriented to person, delirious, unable to tolerate or participate meaningfully in the group, or otherwise unable to provide consent to research and psychotherapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Treatment
Treatment group will receive Awareness, Courage, and Love Groups for loneliness.
|
Groups based on the Awareness, Courage, and Love framework from functional analytic psychotherapy
|
|
Active Comparator: Control
Control group will receive treatment as usual in the form of Mutual Help Meetings.
|
Groups based on treatment as usual where patients gather to discuss how they can help others on the ward, and make requests for how others can help them.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Inclusion of Other in the Self Scale (IOS)
Time Frame: Up to 2 months
|
Brief single-item pictorial measure of social closeness.
The minimum value is 1, the maximum value is 7, and higher scores indicate a better outcome.
|
Up to 2 months
|
|
UCLA Loneliness Scale (ULS-6)
Time Frame: Up to 2 months
|
Brief measure of loneliness.
The minimum value is 6, the maximum value is 24, and higher scores indicate a worse outcome.
|
Up to 2 months
|
|
Relational Health Indices (RHI)
Time Frame: Up to 2 months
|
Brief measure of group relational health.
The minimum value is 8, the maximum value is 40, and higher scores indicate a better outcome.
|
Up to 2 months
|
|
Quantitative Program Satisfaction
Time Frame: Up to 2 months
|
Brief measure of program satisfaction.
The minimum value is 0, the maximum value is 16, and higher scores indicate a better outcome.
|
Up to 2 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cantril Self-Anchoring Striving Scale
Time Frame: Up to 2 months
|
1 item pictorial scale of subjective wellbeing from 0 (minimum) to 10 (maximum).
A higher score indicates a better outcome.
|
Up to 2 months
|
|
Sacred Moment Qualities (SMQ)
Time Frame: Up to 2 months
|
Brief measure of perceived sacred qualities, adapted from Pargament et al. (2014).
The minimum value is 11, the maximum value is 55, and higher scores indicate a better outcome.
|
Up to 2 months
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction Questionnaire
Time Frame: Up to 2 months
|
Brief open-ended questions about program satisfaction.
Responses are qualitative.
|
Up to 2 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Elisabeth VanBussel, MD, St. Joseph's Health Care London
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 12528
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.